Croom Medical launches Biofuse AM platform for implants
Croom Medical, based in Limerick, Ireland, has announced the launch of Biofuse, a porous ingrowth platform produced via Laser Beam Powder Bed Fusion (PBF-LB) Additive Manufacturing.
Biofuse integrates fully interconnected porous architectures directly into implant geometries, reportedly giving OEMs precise control over pore size, porosity, and lattice gradients. By combining dense and porous regions in a single build, it enables tailored ingrowth conditions while streamlining production and preserving feature fidelity.
Unlike traditional surface treatments such as spray coating or laser texturing, which provide only limited porosity, Biofuse is able to form porous structures built across both surface and sub-surface regions. According to the company, this eliminates delamination risks, removes coating and machining steps, and may enable greater structural integrity and consistent quality, even in complex geometries. Croom anticipates that Biofuse will offer a more predictable path from design transfer through to validated production, helping OEMs accelerate development and deliver implants with enhanced performance.
Article: Inside Nikon’s metal AM strategy
Part 2: Scaling industrial production in Long Beach
| Read now |
“Biofuse draws on our additive experience, where we’ve seen firsthand how components can be both faster and more cost‑effective to print than to machine,” said Sean McConnell, Engineering & NPI Manager at Croom Medical. “Embedding lattice structures directly into the build removes coating and machining steps. The result is a more predictable manufacturing process that consolidates production, preserves structural integrity, and helps OEMs bring implants to market faster.”
Dr Bryan Naab, Additive Lead at Croom Medical, added, “With Biofuse, customers can design lattices to their exact requirements. That might mean replicating a porous structure previously produced through coating methods, or proposing lattice characteristics. The flexibility of the platform gives OEMs confidence that their design intent can be realised consistently and in line with regulatory expectations.”
Biofuse is now available through Croom Medical’s Additive Manufacturing offering, supporting projects from early design through full-scale production.
